S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China

Keala Milles, Contributing Author at MarketBeat

Keala Milles

About Keala Milles

Contributing Author: HealthCare and Pharma

Keala is an experienced freelance writer and has written for a wide variety of websites and has covered many topics, from stock market tips to consumer goods, with a specialty in healthcare and pharmaceutical stocks. He has experience with aggregate news writing, press releases and content pages. His strong media and communication background includes a bachelor of arts degree focused on drama and dramatics/theater arts from the University of Washington.

Contact Keala Milles via email at kealamilles@gmail.com.

Articles by Keala Milles

Mergers and Acquisitions in 2023 Off To A Strong Start
Mergers and Acquisitions in 2023 Off To A Strong Start
January 26th, 2023  8:17 AM

Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.

How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
January 25th, 2023  4:03 AM

Five biotechs have already issued layoffs in 2023. Many seem to have good potential, but time will tell if the shifts create the value analysts anticipate.

Low-Priced Stocks Still Paying Dividends
Low-Priced Stocks Still Paying Dividends
January 24th, 2023  7:00 AM

These stocks fell last year, which helped boost their dividends. Now around $10 a share each, they offer great value, but could also have more risk.

Does a Price Cut for Tesla Vehicles Mean the Same for TSLA Stock?
Does a Price Cut for Tesla Vehicles Mean the Same for TSLA Stock?
January 19th, 2023  11:40 AM

Tesla announced price cuts on popular models in order to boost sales, after several earnings misses. Hopefull this can build momentum to restore stock value

Why is T-mobile Down Despite Strong Preliminary Q4 Results?
Why is T-mobile Down Despite Strong Preliminary Q4 Results?
January 19th, 2023  9:19 AM

Despite a positive preliminary earnings report, Tmobile stock is slipping. This article investigates some of the factors that may be contributing to the dip.

Does it Matter Folks Aren
Does it Matter Folks Aren't “Starry-Eyed” Over Pepsi's New Soda?
January 18th, 2023  5:00 AM

Pepsi introduced a new lemon-lime beverage, "Starry" to somewhat poor reception, but that does not seem to affect long-term growth.

 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
January 13th, 2023  3:00 AM

Health care stocks are trying to make a comeback and these three small-cap biopharma companies are leading the charge in some ways.

2 Biotechs Making Waves With A Single Product in their Pipeline
2 Biotechs Making Waves With A Single Product in their Pipeline
January 11th, 2023  10:10 AM

Catalyst Pharmaceuticals and Harmony Bioscience each have a single product in their respective pipelines, and both show incredible promise.

What Does Amazon
What Does Amazon's Acquisition of 1LifeMedical Mean To Investors?
January 10th, 2023  3:00 AM

After the announcement in July, the Amazon acquisition of One Medical is complete. What does this deal mean for healthcare or tech investors?

Four Undervalued Healthcare Stocks for 2023
Four Undervalued Healthcare Stocks for 2023
January 6th, 2023  11:20 AM

These four health care stocks could be undervalued: Pfizer Inc., Regeneron Pharmaceuticals Inc., Innoviva Inc. and Exelixis Inc.

How 2022
How 2022's Biggest Healthcare Gainers Could Fare In 2023
January 6th, 2023  8:00 AM

Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023

3 Health Care Stocks Paying Reliable Dividends
3 Health Care Stocks Paying Reliable Dividends
January 5th, 2023  1:00 AM

Premier Inc, Patterson Companies, Inc, and Walgreens Boots Alliance, Inc are three healthcare stocks consistently paying decent-to-great dividends

Is Kintara Therapeutics A Hidden Gem?
Is Kintara Therapeutics A Hidden Gem?
December 30th, 2022  1:00 AM

Kintara Therapeutics' earnings are in the red but impressive FDA approvals could satisfy an extreme upside potential to bring them solvent by next year.

Big Health Care Stocks to Watch in the New Year
Big Health Care Stocks to Watch in the New Year
December 29th, 2022  1:00 AM

Here are three health care stocks to watch as the New Year begins. Two have a moderate Buy rating while one is a Hold, for now.

Why Did Immutep Ltd Stock Soar Recently?
Why Did Immutep Ltd Stock Soar Recently?
December 28th, 2022  2:00 AM

Analysts and investors alike appear enamored with Immutep Ltd, whose earnings are growing; more of which could come from their latest product candidate.

Three Healthcare Penny Stocks to Watch In The New Year
Three Healthcare Penny Stocks to Watch In The New Year
December 27th, 2022  1:00 AM

These three penny (and nickel) stocks in the healthcare sector have a lot of potential for 2023, and definitely worth watching.

Why Did Viking Therapeutics Stock Skyrocket
Why Did Viking Therapeutics Stock Skyrocket
December 21st, 2022  10:00 AM

VKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial.

Eli Lilly Expects Enduring Growth, Despite Immediate Challenges
Eli Lilly Expects Enduring Growth, Despite Immediate Challenges
December 19th, 2022  1:00 PM

Eli Lilly & Co may be struggling with supply-side issues but new partnerships and a healthy dividend are helping to keep up their momentum

Can FDA Approval Bolster DexCom, Inc.?
Can FDA Approval Bolster DexCom, Inc.?
December 14th, 2022  1:00 AM

Dexcom is relying on the interest and sales of its new continuous glucose monitor--which recently received FDA approval--to boost revenue (and stock value).

Can Cano Health Recover From the Recent Sell-Off?
Can Cano Health Recover From the Recent Sell-Off?
December 12th, 2022  8:00 AM

Revenue loss and a recent sell-off confirm that Cano Health stock may be struggling right now but a membership-focused strategy could help them recover.

Costco vs Amazon: an end of the year showdown
Costco vs Amazon: an end of the year showdown
December 9th, 2022  8:00 AM

How do Costco Wholesale and Amazon.com compare at the end of the year, and does this information affect their moderate buy ratings?

Discount Retailers Could Make Good Bargain Stocks
Discount Retailers Could Make Good Bargain Stocks
December 9th, 2022  7:00 AM

Discount retailers can be strong stock investments as their share price is often more appealing though they are not always reliable

3 Big Box Retail Bets for the Holidays
3 Big Box Retail Bets for the Holidays
December 6th, 2022  12:00 PM

Christmas time tends to be big for retailers, which can make them good bets for investors. Here are three moderate buy stocks as we approach year's end.

Why CSL Ltd Stock Could Be Worth a Look
Why CSL Ltd Stock Could Be Worth a Look
December 3rd, 2022  2:00 AM

FDA approval of costly--but worthwhile--drug leads the momentum that could make CSL Ltd an equally worthwhile investment.

Okta Inc Celebrates Earnings Beat But Can They Sustain the Boost?
Okta Inc Celebrates Earnings Beat But Can They Sustain the Boost?
December 2nd, 2022  12:00 PM

Okta is struggling but a recent earnings beat has boosted expectations. Can they maintain this momentum and get out of the red?

Struggling Axsome Stock Could Bounce Back on Drug Trial Success
Struggling Axsome Stock Could Bounce Back on Drug Trial Success
November 30th, 2022  8:00 AM

Axsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that.

Is Snowflake Poised for A Rebound After Its Recent Tumble?
Is Snowflake Poised for A Rebound After Its Recent Tumble?
November 28th, 2022  11:00 AM

The cloud computing industry appears to be slowing but many stocks in the sector are a moderate buy. This means long term outlook is positive.

Can Rambus Maintain Momentum to Regain Recent Losses?
Can Rambus Maintain Momentum to Regain Recent Losses?
November 28th, 2022  1:34 AM

Rambus Inc grew quickly since its ipo but slipped lately. Rebounds tend to grow further, though, so analysts think it could continue this trend

Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
November 23rd, 2022  12:00 PM

Salesforce, climbing out of a rough spot, still may not make the best short-term investment. In the future, it could make a big move.

Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
November 22nd, 2022  10:00 AM

Cisco Systems has expanded operations and expect revenue to grow but have recently announced a restructuring plan that could help.

Is This The Right Time to Invest in Alibaba?
Is This The Right Time to Invest in Alibaba?
November 22nd, 2022  5:00 AM

Without the ability to turn significant profits, Alibaba is struggling. Fortunately, the industry as a whole is facing challenges, so watch the sector closely.

Is Ardelyx is A Buy After Slip in Early 2022
Is Ardelyx is A Buy After Slip in Early 2022
November 21st, 2022  1:00 PM

Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them

Solid Earnings and Potential Growth Make Costco a Moderate Buy
Solid Earnings and Potential Growth Make Costco a Moderate Buy
November 17th, 2022  1:00 AM

Costco has had strong earnings and analysts project the growth will continue but comparable data shows this may be consistent across the industry

Four Healthcare Stocks To Watch This Week
Four Healthcare Stocks To Watch This Week
November 16th, 2022  8:00 AM

Healthcare has long been a wise investment, as the industry consistently grows yearly. Some analysts believe that trend will continue.

Three Penny Stocks Making Big Moves In November
Three Penny Stocks Making Big Moves In November
November 15th, 2022  8:00 AM

Penny stocks are cheap, but risky because they can shift quickly and in big ways. Here are two penny stocks making moves up and one heading down.

Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
November 11th, 2022  1:00 AM

Vision Hydrogen Corporation decalred 2-for-1 split and changed their name to Vision Energy; Along with their green energy projects, this should entice investors

Analysts Rate DraftKings a Moderate Buy As Growth Slows
Analysts Rate DraftKings a Moderate Buy As Growth Slows
November 10th, 2022  1:00 AM

DraftKings share price continues to slip, even with a revenue beat and fewer losses than expected, and analysts have rated the stock a moderate Buy.

DoorDash Outperforms Despite Losses - Is It Time To Buy?
DoorDash Outperforms Despite Losses - Is It Time To Buy?
November 10th, 2022  1:00 AM

DoorDash has not done too well since its IPO but in a couple years, sales have improved greatly. Don't let sluggish earnings deter you from a potential buy.

Despite Financials, Twilio is One To Watch
Despite Financials, Twilio is One To Watch
November 8th, 2022  7:00 AM

Twilio's financials suggest uncertainty but analysts believe a rebound may be coming soon, as they give it a HOLD rating.

Mixed Results Actually Bring More Optimism than Risk for AMD
Mixed Results Actually Bring More Optimism than Risk for AMD
November 4th, 2022  1:00 AM

AMD is down but this could be the start of another rebound as sales and earnings show promise in the long term, particularly when compared against competitors.

Paypal Shows Promise With Strong Buy Rating
Paypal Shows Promise With Strong Buy Rating
November 3rd, 2022  7:00 AM

Analysts believe Paypal could be a Strong Buy as earnings are not only steady but growing, even amid tough competition; thanks to resilient sales.

New Revenue Strategy, Strong Earnings, Apple Remains a Buy
New Revenue Strategy, Strong Earnings, Apple Remains a Buy
November 3rd, 2022  1:13 AM

Apple could have better long-term promise than its peers and industry thanks to strong earnings and a new revenue strategy.

The Trade Desk Has Room and Momentum For Growth
The Trade Desk Has Room and Momentum For Growth
November 2nd, 2022  2:00 AM

TTD may not always have the best numbers but they consistently outpace their competitors and have excellent guidance for the next quarter and full-year.

ExxonMobil Stock is Rising. Is it Time to Buy?
ExxonMobil Stock is Rising. Is it Time to Buy?
October 25th, 2022  12:00 PM

ExxonMobil stock started the year strong and growth may beat others in the black gold industry. Analysts have given ExxonMobil a "moderate buy" rating

Impressive Numbers Could Mean Netflix on the Way Back
Impressive Numbers Could Mean Netflix on the Way Back
October 21st, 2022  1:00 AM

New subscriptions have helped raise NFLX guidance, but extreme volatility keep analyst to a conservative HOLD rating, awaiting the next earnings report.

With Stable Growth, Do Analysts Believe NEE Is a Good BUY?
With Stable Growth, Do Analysts Believe NEE Is a Good BUY?
October 18th, 2022  8:00 AM

NextEra Energy may not always have better numbers than competitors, but steady growth and an impressive upside could make it a worthy investment.

Eli Lilly Stock is a Strong Buy After New Drug Approval
Eli Lilly Stock is a Strong Buy After New Drug Approval
October 17th, 2022  1:00 AM

Analysts seem to agree that steady and stable growth coupled with a potentially best-selling T2D medication makes LLY a STRONG BUY

Does Kraft Heinz Company
Does Kraft Heinz Company's Steady Stability Make it a Smart Buy?
October 13th, 2022  11:00 AM

Despite a small pandemic hiccup, Kraft Heinz shows great solid earnings and strong momentum promise. But is it a portfolio-worthy consumer staples heavy hitter?

APA Corporation: An Energy Stock on the Move
APA Corporation: An Energy Stock on the Move
October 11th, 2022  10:00 AM

APA Corporation stock holds strong while other energy companies struggle. Is the a safer and more affordable option than competitors?

Consistent Growth Could Make General Motors a Smart Buy
Consistent Growth Could Make General Motors a Smart Buy
October 6th, 2022  11:00 AM

General Motors' consistent earnings beats compared to the rest of the industry coupled with strong outlook makes it tempting for investors.